Abgeschlossene Studien
Apeptico-Trial
Safety and preliminary efficacy of sequential multiple ascending doses of solnatide to treat pulmonary permeability oedema in patients with moderate-to severe ARDS - a randomised, placebo-controlled, double-blind trial
Bayer
Exploratory study to investigate the association between the onset of disseminated intravascular coagulation (DIC) and disease progression with different biomarker candidates as well as standard clinical and demographic parameters in adult patients with sepsis.
ALF
Etablierung einer Methode zur Gewinnung von interstitieller Lungenflüssigkeit und Epithelial Lining Fluid zur Messung von Antibiotikakonzentrationen aus explantiertem Lungengewebe
(Machbarkeitsstudie)
MobiStar
Untersuchung des Effekts von roboterassistierter Frühmobilisation auf kritisch kranke Patient*innen, auf das Mobilisationsverhalten und -erleben der mobilisierenden Fachpersonen und die organisationalen Prozesse auf einer Intensivstation
DigiSep
A Phase IIb/III operationally seamless, open-label, randomised, sequential, parallel-group adaptive study to evaluate the efficacy and safety of daily intravenous alteplase treatment given up to 5 days on top of standard of care (SOC) compared with SOC alone, in patients with acute respiratory distress syndrome (ARDS)
Tristards
A Phase IIb/III operationally seamless, open-label, randomised, sequential, parallel-group adaptive study to evaluate the efficacy and safety of daily intravenous alteplase treatment given up to 5 days on top of standard of care (SOC) compared with SOC alone, in patients with acute respiratory distress syndrome (ARDS)
ProCyss
A prospective, randomized, multicenter, single-blind, controlled study to assess the performance of the CytoSorb® 300 mL device for shock reversal in patients with vasoplegic septic shock
Cyto-Solve
Prospektive Qualitätssicherungsstudie zur Anwendung von Cytosorb® bei Patienten mit Zyotkinsturm, Rhabdomyolyse und akutem Leberversagen
MultiPlus Fresenius
Safety and performance evaluation of multiPlus dialysate during CRRT
CorKUM
Covid-19 Register LMU Klinikums
EMIL
Evaluation eines TDM-Programms von Intensivpatienten im Liquor
ARISS
Randomisierte kontrollierte multizentrische Studie zur Albuminersatztherapie im septischen Schock
TriCovid
A randomized, placebo-controlled, double-blind, multi-center, phase III trial to assess the efficacy and safety of trimodulin (BT588) in adult hospitalized subjects with CAP including COVID-19 pneumonia.
LandiSep
Phase IV, multicenter, prospective, randomized, open-label, controlled study on Landiolol in patients with septic shock resident in an Intensive Care Unit
INSIC-Trial
Incidence of Sepsis-induced Coagulopathy
